Literature DB >> 32640882

Atrial fibrillation trial to evaluate real-world procedures for their utility in helping to lower stroke events: A randomized clinical trial.

Wen-Yi Huang1, Meng Lee1, Sheng-Feng Sung2, Sung-Chun Tang3, Kuo-Hsuan Chang1, Yung-Sung Huang4, Jiann-Der Lee1, Tsong-Hai Lee1, Jiann-Shing Jeng3, Chang-Min Chung5, Yi-Ling Wu6, Tsung-Ta Hsieh1, Bruce Ovbiagele7.   

Abstract

BACKGROUND: Enhancing detection of unrecognized atrial fibrillation among acute ischemic stroke patients is crucial for secondary stroke prevention. AIM: To evaluate whether the detection rate of new atrial fibrillation in acute ischemic stroke patients without known atrial fibrillation could be improved by doing serial 12-lead electrocardiograms once daily for five days, compared with conventional 24-h Holter monitoring (24-h Holter).
METHODS: We conducted a randomized clinical trial to compare the detection rates of paroxysmal atrial fibrillation between serial electrocardiograms versus 24-h Holter from October 2015 to October 2018 at six hospitals. Eligible participants were acute ischemic stroke patients with aged ≥65 years, with neither atrial fibrillation history nor any presence of atrial fibrillation on baseline electrocardiogram at admission. The primary outcome was newly detected electrocardiogram in the serial electrocardiograms and 24-h Holter group.
RESULTS: Among 826 patients, baseline characteristics were similar between both groups. In the intention-to-treat analysis, there was no statistical difference between serial electrocardiograms versus 24-Holter to detect atrial fibrillation (8.4% vs. 6.9%; adjusted odds ratio 1.17, 95% confidence interval 0.69-2.01). Stepwise multivariate logistic regression revealed age ≥80 years and history of heart failure were associated with detection of paroxysmal atrial fibrillation whereas patients with lacunar infarction had lower odds for detection of paroxysmal atrial fibrillation.
CONCLUSIONS: Serial electrocardiograms had comparable detection rate of paroxysmal atrial fibrillation compared with 24-h Holter and might be a viable alternative to 24-h Holter as a first-line approach to survey for potential paroxysmal atrial fibrillation among elderly patients with acute ischemic stroke.Clinical Trial Registration: URL https://clinicaltrials.gov/ct2/show/NCT02578979Unique Identifiers: NCT02578979.

Entities:  

Keywords:  24-h Holter; Atrial fibrillation; electrocardiography; randomized controlled trial; stroke

Year:  2020        PMID: 32640882     DOI: 10.1177/1747493020938297

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  3 in total

1.  Statin and dual antiplatelet therapy for the prevention of early neurological deterioration and recurrent stroke in branch atheromatous disease: a protocol for a prospective single-arm study using a historical control for comparison.

Authors:  Yen-Chu Huang; Jiann-Der Lee; Hsu-Huei Weng; Leng-Chieh Lin; Yuan-Hsiung Tsai; Jen-Tsung Yang
Journal:  BMJ Open       Date:  2021-11-26       Impact factor: 2.692

2.  Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke.

Authors:  Jin-Yi Hsu; Peter Pin-Sung Liu; Luciano A Sposato; Huei-Kai Huang; An-Bang Liu; Edward Chia-Cheng Lai; Swu-Jane Lin; Cheng-Yang Hsieh; Ching-Hui Loh
Journal:  Front Cardiovasc Med       Date:  2022-07-22

3.  Identification of magnetic resonance imaging features for the prediction of unrecognized atrial fibrillation in acute ischemic stroke.

Authors:  Chao-Hui Chen; Meng Lee; Hsu-Huei Weng; Jiann-Der Lee; Jen-Tsung Yang; Yuan-Hsiung Tsai; Yen-Chu Huang
Journal:  Front Neurol       Date:  2022-09-13       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.